Pediatric Brain Tumors Global Market Report 2025

Description

Pediatric brain tumors are abnormal cell growths in the brain or central nervous system (CNS) of children, which can be either benign (non-cancerous) or malignant (cancerous). These tumors may develop in different areas of the brain or spinal cord, with treatment aimed at shrinking or removing the tumor, alleviating symptoms, and preserving cognitive and motor functions to support the child's long-term health and development.

The primary types of pediatric brain tumors include gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma or carcinoma, tumors arising from non-neuroepithelial tissue, and meningeal tumors. Gliomas are the most common type, originating from glial cells and requiring aggressive treatment due to their infiltrative growth and high recurrence potential. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, while diagnostic methods involve imaging techniques, biopsy, neurological exams, and lumbar puncture. Pediatric brain tumors can occur in various age groups, including infants, toddlers, children, and adolescents, and are managed in settings such as hospitals and clinics, medical research centers, academic institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pediatric brain tumor market research report is one of a series of new reports from The Business Research Company that provides pediatric brain tumor market statistics, including the pediatric brain tumor industry global market size, regional shares, competitors with the pediatric brain tumor market share, detailed pediatric brain tumor market segments, market trends, and opportunities, and any further data you may need to thrive in the pediatric brain tumor industry. This pediatric brain tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pediatric brain tumors market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the increasing incidence of pediatric brain tumors, emerging economies, growing investment in research and development, and growing demand for diagnostic technology, and the cases of pediatric tumors are increasing globally.

The pediatric brain tumors market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine, molecular profiling, targeted therapy, rising healthcare infrastructure, and extended insurance coverage. Major trends in the forecast period include the advancements in magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) scanning technologies, the use of genetic and molecular profiling, the development of targeted therapies, the introduction of immunotherapies, the rise of minimally invasive surgical techniques.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision pediatric neuro-oncology by inflating prices of MRI-guided laser ablation devices and targeted therapy drugs developed in Canada and Germany, resulting in delayed tumor resections and higher neurosurgical costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for personalized medicine is expected to drive growth in the pediatric brain tumors market. Personalized medicine is a healthcare approach that tailors treatments and medical decisions to an individual's genetic profile, lifestyle, and specific health needs. The demand for personalized medicine is rising due to advancements in genetic research, improved diagnostic tools, and the potential for more precise and effective treatments. By customizing therapies based on a child's tumor type, genetic mutations, and response patterns, personalized medicine enhances treatment outcomes while minimizing damage to healthy tissue and reducing side effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. As a result, the growing demand for personalized medicine is fueling the expansion of the pediatric brain tumor market.

Companies in the pediatric brain tumors market are focusing on developing innovative treatments such as type II RAF inhibitors to improve targeted therapies and enhance patient outcomes. Type II RAF inhibitors work by selectively inhibiting RAF kinases, particularly those with mutations that promote tumor growth. These inhibitors target abnormal RAF protein structures found in certain pediatric low-grade glioma (pLGG) subtypes, effectively disrupting faulty signaling pathways that contribute to tumor cell proliferation and survival. For example, in April 2024, Day One Biopharmaceuticals, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for OJEMDA (tovorafenib) for the treatment of relapsed or refractory pediatric low-grade glioma (pLGG) in patients aged six months and older with specific BRAF alterations. This approval marks OJEMDA as the first FDA-approved therapy targeting BRAF fusions or mutations in this patient group. The decision was based on data from the FIREFLY-1 clinical trial, which demonstrated an overall response rate of 51%, highlighting the drug's efficacy in treating pediatric brain tumors that have not responded to prior treatments.

In July 2024, Ipsen, a France-based biopharmaceutical company, entered into a partnership with Day One Biopharmaceuticals to commercialize tovorafenib for pediatric low-grade glioma (pLGG) outside the United States. Through this collaboration, Ipsen will manage the regulatory and commercial aspects of tovorafenib's global expansion. Day One Biopharmaceuticals, a US-based company specializing in treatments for childhood brain tumors, developed OJEMDA to address the unmet medical needs of pediatric patients.

Major players in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., and Seattle Children's Therapeutics

North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in pediatric brain tumors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric brain tumors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric brain tumor market consists of revenues earned by entities providing services such as neuro-oncology care, rehabilitation services, psychosocial support, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric brain tumor market also includes sales of chemotherapy drugs, surgical instruments, and radiation therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Brain Tumors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric brain tumors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric brain tumors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric brain tumors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Gliomas; Mixed Neuronal-Glial Tumors; Embryonal Tumors; Choroid Plexus Papilloma Or Carcinoma; Tumors Arising From Non-Neuroepithelial Tissue; Meningeal Tumors
2) By Treatment Type: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
3) By Diagnosis Method: Imaging Techniques; Biopsy; Neurological Exam; Lumbar Puncture
4) By Age Group: Infants; Toddlers; Children; Adolescents
5) By Application: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other Applications
Subsegments:
1) By Gliomas: Low-Grade Gliomas; High-Grade Gliomas
2) By Mixed Neuronal-Glial Tumors: Gangliogliomas; Dysembryoplastic Neuroepithelial Tumors (DNET)
3) By Embryonal Tumors: Medulloblastoma; Atypical Teratoid Rhabdoid Tumor (ATRT); Primitive Neuroectodermal Tumors (PNET)
4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma; Choroid Plexus Carcinoma
5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma; Ewing's Sarcoma
6) By Meningeal Tumors: Meningiomas; Hemangiopericytomas
Companies Mentioned: AbbVie Inc.; Bayer AG; Novartis AG; Roche Holding AG; Takeda Pharmaceutical Company; UCLA Health; Ipsen Pharma; Novocure; Blueprint Medicines; Karyopharm Therapeutics Inc.; Renaissance Pharma; Servier Laboratories; Matica Biotechnology; Curis Inc.; Oncoheroes Biosciences; Treovir Inc.; Plus Therapeutics Inc.; Stemline Therapeutics Inc.; BrainChild Bio Inc.; Seattle Children's Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34114u

1. Executive Summary

2. Pediatric Brain Tumors Market Characteristics

3. Pediatric Brain Tumors Market Trends And Strategies

4. Pediatric Brain Tumors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pediatric Brain Tumors Growth Analysis And Strategic Analysis Framework

5.1. Global Pediatric Brain Tumors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pediatric Brain Tumors Market Growth Rate Analysis
5.4. Global Pediatric Brain Tumors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pediatric Brain Tumors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pediatric Brain Tumors Total Addressable Market (TAM)

6. Pediatric Brain Tumors Market Segmentation

6.1. Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gliomas
Mixed Neuronal-Glial Tumors
Embryonal Tumors
Choroid Plexus Papilloma Or Carcinoma
Tumors Arising From Non-Neuroepithelial Tissue
Meningeal Tumors
6.2. Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy
Immunotherapy
6.3. Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Techniques
Biopsy
Neurological Exam
Lumbar Puncture
6.4. Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infants
Toddlers
Children
Adolescents
6.5. Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Medical Research Centers
Academic Institutes
Other Applications
6.6. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low-Grade Gliomas
High-Grade Gliomas
6.7. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gangliogliomas
Dysembryoplastic Neuroepithelial Tumors (DNET)
6.8. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medulloblastoma
Atypical Teratoid Rhabdoid Tumor (ATRT)
Primitive Neuroectodermal Tumors (PNET)
6.9. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Choroid Plexus Papilloma
Choroid Plexus Carcinoma
6.10. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rhabdomyosarcoma
Ewing's Sarcoma
6.11. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Meningiomas
Hemangiopericytomas

7. Pediatric Brain Tumors Market Regional And Country Analysis

7.1. Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Brain Tumors Market

8.1. Asia-Pacific Pediatric Brain Tumors Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Brain Tumors Market

9.1. China Pediatric Brain Tumors Market Overview
9.2. China Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Brain Tumors Market

10.1. India Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Brain Tumors Market

11.1. Japan Pediatric Brain Tumors Market Overview
11.2. Japan Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Brain Tumors Market

12.1. Australia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Brain Tumors Market

13.1. Indonesia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Brain Tumors Market

14.1. South Korea Pediatric Brain Tumors Market Overview
14.2. South Korea Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Brain Tumors Market

15.1. Western Europe Pediatric Brain Tumors Market Overview
15.2. Western Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Brain Tumors Market

16.1. UK Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Brain Tumors Market

17.1. Germany Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Brain Tumors Market

18.1. France Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Brain Tumors Market

19.1. Italy Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Brain Tumors Market

20.1. Spain Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Brain Tumors Market

21.1. Eastern Europe Pediatric Brain Tumors Market Overview
21.2. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Brain Tumors Market

22.1. Russia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Brain Tumors Market

23.1. North America Pediatric Brain Tumors Market Overview
23.2. North America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Brain Tumors Market

24.1. USA Pediatric Brain Tumors Market Overview
24.2. USA Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Brain Tumors Market

25.1. Canada Pediatric Brain Tumors Market Overview
25.2. Canada Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Brain Tumors Market

26.1. South America Pediatric Brain Tumors Market Overview
26.2. South America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Brain Tumors Market

27.1. Brazil Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Brain Tumors Market

28.1. Middle East Pediatric Brain Tumors Market Overview
28.2. Middle East Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Brain Tumors Market

29.1. Africa Pediatric Brain Tumors Market Overview
29.2. Africa Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Brain Tumors Market Competitive Landscape And Company Profiles

30.1. Pediatric Brain Tumors Market Competitive Landscape
30.2. Pediatric Brain Tumors Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Brain Tumors Market Other Major And Innovative Companies

31.1. UCLA Health
31.2. Ipsen Pharma
31.3. Novocure
31.4. Blueprint Medicines
31.5. Karyopharm Therapeutics Inc.
31.6. Renaissance Pharma
31.7. Servier Laboratories
31.8. Matica Biotechnology
31.9. Curis Inc.
31.10. Oncoheroes Biosciences
31.11. Treovir Inc.
31.12. Plus Therapeutics Inc.
31.13. Stemline Therapeutics Inc.
31.14. BrainChild Bio Inc.
31.15. Seattle Children's Therapeutics

32. Global Pediatric Brain Tumors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Brain Tumors Market

34. Recent Developments In The Pediatric Brain Tumors Market

35. Pediatric Brain Tumors Market High Potential Countries, Segments and Strategies

35.1 Pediatric Brain Tumors Market In 2029 - Countries Offering Most New Opportunities
35.2 Pediatric Brain Tumors Market In 2029 - Segments Offering Most New Opportunities
35.3 Pediatric Brain Tumors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer